Tell me something I didn’t know. retired doc on the Zyprexa scandal.
Related posts:
- "One of the more devious drug marketing campaigns in recent memory"
- Drug companies and medical malpractice
- Ethics in medical blogging
- The ethics of medical blogging
- Dentists are getting into the medical spa business
- Will medical tourism drive domestic doctors out of business?
- Gawande: Nursing home residents "not fundamentally different from prisoners"
KevinMD.com on Facebook
{ 2 comments }
I can remeber Lilly reps coming around with a video lecture the point of which was to convince MDs that most of their depressed patients were, in fact, bipolar and that Zyprexa would help them.
It’s not as nefarious as promoting off-label use, but it is perhaps more insidious.
Eli Lilly zyprexa cost me over $250.00 a month supply and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.
Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to ‘encourage’ doctors to write zyprexa for non-FDA approved ‘off label’ uses.
The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.
I was ordered to take it beginning in 1996 for my PTSD for 4 years more,it was useless for my symptoms.Lesson learned…you shouldn’t give a major tranquilizer like zyprexa which makes you ’sleepy’ to a hyper-vigilant patient.
There is a clinical difference between hyper-vigilant and mania harmful aggression.
Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.
—
Daniel Haszard
Comments on this entry are closed.